The concern of generic competition has repeatedly loomed over copyright’s famous drug, Sildenafil, sparking questions about the outlook of connected drug stakes. While early years saw impressive profits, the exclusivity expiration has allowed the door for cheaper substitutes, possibly lowering earnings and creating a real danger for investors se… Read More